Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
PaperCitations, authors & open-access status
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,112 citations, 2021 year and closed oa status.
1,112
Citations
2021
Year
closed
OA Status